Advertisement
TerrAscend Corp.

TerrAscend Corp. Fundamental Analysis

TER.CNCNQ
HealthcareDrug Manufacturers - Specialty & Generic
$2.38
$0.01(0.42%)
Canadian Market is Open · 10:55
Advertisement

TerrAscend Corp. Fundamental Analysis

TerrAscend Corp. (TER.CN) shows weak financial fundamentals with a PE ratio of -29.13, profit margin of -46.47%, and ROE of -61.75%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.52

Areas of Concern

ROE-61.75%
Operating Margin-7.28%
Cash Position0.71%
We analyze TER.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -111.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-111.7/100

We analyze TER.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

TER.CN struggles to generate sufficient returns from assets.

ROA > 10%
-16.60%

Valuation Score

Excellent

TER.CN trades at attractive valuation levels.

PE < 25
-29.13
PEG Ratio < 2
-0.52

Growth Score

Weak

TER.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

TER.CN shows balanced financial health with some risks.

Debt/Equity < 1
2.05
Current Ratio > 1
1.45

Profitability Score

Weak

TER.CN struggles to sustain strong margins.

ROE > 15%
-6174.67%
Net Margin ≥ 15%
-46.47%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TER.CN Expensive or Cheap?

P/E Ratio

TER.CN trades at -29.13 times earnings. This suggests potential undervaluation.

-29.13

PEG Ratio

When adjusting for growth, TER.CN's PEG of -0.52 indicates potential undervaluation.

-0.52

Price to Book

The market values TerrAscend Corp. at 23.45 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

23.45

EV/EBITDA

Enterprise value stands at 8.36 times EBITDA. This is generally considered low.

8.36

How Well Does TER.CN Make Money?

Net Profit Margin

For every $100 in sales, TerrAscend Corp. keeps $-46.47 as profit after all expenses.

-46.47%

Operating Margin

Core operations generate -7.28 in profit for every $100 in revenue, before interest and taxes.

-7.28%

ROE

Management delivers $-61.75 in profit for every $100 of shareholder equity.

-61.75%

ROA

TerrAscend Corp. generates $-16.60 in profit for every $100 in assets, demonstrating efficient asset deployment.

-16.60%

Following the Money - Real Cash Generation

Operating Cash Flow

TerrAscend Corp. produces operating cash flow of $4.24M, showing steady but balanced cash generation.

$4.24M

Free Cash Flow

TerrAscend Corp. produces free cash flow of $2.31M, offering steady but limited capital for shareholder returns and expansion.

$2.31M

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

TER.CN converts 1.98% of its market value into free cash.

1.98%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-29.13

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.52

vs 25 benchmark

P/B Ratio

Price to book value ratio

23.45

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.78

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

2.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.45

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.62

vs 25 benchmark

ROA

Return on assets percentage

-0.17

vs 25 benchmark

ROCE

Return on capital employed

-0.03

vs 25 benchmark

How TER.CN Stacks Against Its Sector Peers

MetricTER.CN ValueSector AveragePerformance
P/E Ratio-29.1333.74 Better (Cheaper)
ROE-61.75%404.00% Weak
Net Margin-46.47%-40219.00% (disorted) Weak
Debt/Equity2.050.81 Weak (High Leverage)
Current Ratio1.455.53 Neutral
ROA-16.60%-281.00% (disorted) Weak

TER.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews TerrAscend Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ